Cargando…

Successful Control of Hepatitis B Virus Reactivation following Restart of Ibrutinib in Chronic Lymphocytic Leukaemia

Ibrutinib is a targeted therapy drug that blocks the activity of Bruton's tyrosine kinase, and it is an approved treatment for several mature B-cell malignancies including chronic lymphocytic leukaemia (CLL). Side effects include infections, cytopenia, nausea, and diarrhoea. In this report, we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tjønnfjord, Sara Kristina Viberg, Tjønnfjord, Eirik Brekka, Konopski, Zbigniew, Tjønnfjord, Geir Erland
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553503/ https://www.ncbi.nlm.nih.gov/pubmed/34721911 http://dx.doi.org/10.1155/2021/1862446

Ejemplares similares

National trends in incidence and survival of chronic lymphocytic leukemia in Norway for 1953–2012: a systematic analysis of population‐based data
por: Lenartova, Andrea, et al.
Publicado: (2016)

Cytokinesis arrest and multiple centrosomes in B cell chronic lymphocytic leukaemia
por: Rogne, Marie, et al.
Publicado: (2018)

PB2608: THE MANAGEMENT OF IMMUNE THROMBOCYTOPENIA (ITP) IN NORWAY IN THE REAL LIFE – ANALYSIS OF THE NOR-ITP REGISTRY
por: Ilicheva, Ekaterina, et al.
Publicado: (2023)

Determining drug dose in the era of targeted therapies: playing it (un)safe?
por: Skånland, Sigrid S., et al.
Publicado: (2022)

Factor eight inhibitor bypass activity (FEIBA) in the management of bleeds in hemophilia patients with high-titer inhibitors
por: Tjønnfjord, Geir E, et al.
Publicado: (2007)

Anticipation in Families with Chronic Lymphocytic Leukemia and Other Lymphoproliferative Disorders
por: Awan, Haneef, et al.
Publicado: (2010)

Primary chronic cold agglutinin disease: An update on pathogenesis, clinical features and therapy
por: Berentsen, Sigbjørn, et al.
Publicado: (2007)

Possible Imprinting and Microchimerism in Chronic Lymphocytic Leukemia and Related Lymphoproliferative Disorders
por: Jønsson, Viggo, et al.
Publicado: (2008)

Meiotic drive in chronic lymphocytic leukemia compared with other malignant blood disorders
por: Jønsson, Viggo, et al.
Publicado: (2022)

Successful treatment of subcorneal pustular dermatosis targeting an underlying monoclonal IgA gammopathy
por: Kreyberg, Ina, et al.
Publicado: (2023)

A Case of Posttransfusion Purpura with Severe Refractory Thrombocytopenia but No Cutaneous Manifestations
por: Bhamra, Jagjit Singh, et al.
Publicado: (2018)

Improved outcome in patients following autologous stem cell transplantation for multiple myeloma in south eastern Norway 2001–2010: a retrospective, population based analysis
por: Tangen, Jon-Magnus, et al.
Publicado: (2018)

Neoplastic plasma cells with Auer rod‐like inclusions
por: Jakob, Nordberg Nørgaard, et al.
Publicado: (2020)

Two Consecutive Episodes of Severe Delayed Hemolytic Transfusion Reaction in a Sickle Cell Disease Patient
por: Mpinganzima, Clarisse, et al.
Publicado: (2020)

Functional testing of relapsed chronic lymphocytic leukemia guides precision medicine and maps response and resistance mechanisms. An index case
por: Skånland, Sigrid S., et al.
Publicado: (2022)

Single cell profiling of phospho-protein levels in chronic lymphocytic leukemia
por: Myhrvold, Ida K., et al.
Publicado: (2018)

Cold agglutinin disease: current challenges and future prospects
por: Berentsen, Sigbjørn, et al.
Publicado: (2019)

T‐helper cell regulation of CD45 phosphatase activity by galectin‐1 and CD43 governs chronic lymphocytic leukaemia proliferation
por: Imbery, John F., et al.
Publicado: (2022)

The prognostic value of patient-reported outcomes in allogeneic hematopoietic stem cell transplantation: exploratory analysis of a randomized nutrition intervention trial
por: Gudmundstuen, Anne Marte, et al.
Publicado: (2023)

Novel ZEB2-BCL11B Fusion Gene Identified by RNA-Sequencing in Acute Myeloid Leukemia with t(2;14)(q22;q32)
por: Torkildsen, Synne, et al.
Publicado: (2015)

Comparison between Karyotyping-FISH-Reverse Transcription PCR and RNA- Sequencing-Fusion Gene Identification Programs in the Detection of KAT6A-CREBBP in Acute Myeloid Leukemia
por: Panagopoulos, Ioannis, et al.
Publicado: (2014)

Cryopreservation of primary B cells minimally influences their signaling responses
por: Hermansen, Johanne U., et al.
Publicado: (2018)

Immunomodulatory Effects of the Agaricus blazei Murrill-Based Mushroom Extract AndoSan in Patients with Multiple Myeloma Undergoing High Dose Chemotherapy and Autologous Stem Cell Transplantation: A Randomized, Double Blinded Clinical Study
por: Tangen, Jon-Magnus, et al.
Publicado: (2015)

S144: BTK AND BCL-2 ACTIVITY AT BASELINE PREDICTS MRD STATUS FOR CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH IBRUTINIB + VENETOCLAX IN THE HOVON 141/VISION TRIAL
por: Urban, Aleksandra, et al.
Publicado: (2023)

Venous thromboembolism and coronavirus disease 2019 in an ambulatory care setting - A report of 4 cases
por: Overstad, Siri, et al.
Publicado: (2020)

Antitumor, Anti-inflammatory and Antiallergic Effects of Agaricus blazei Mushroom Extract and the Related Medicinal Basidiomycetes Mushrooms, Hericium erinaceus and Grifola frondosa: A Review of Preclinical and Clinical Studies
por: Hetland, Geir, et al.
Publicado: (2020)

Targeted DNA vaccines eliciting crossreactive anti-idiotypic antibody responses against human B cell malignancies in mice
por: Ruffini, Pier Adelchi, et al.
Publicado: (2014)

Ibrutinib induces chromatin reorganisation of chronic lymphocytic leukaemia cells
por: Holmes, Katie B., et al.
Publicado: (2019)

Tissue factor pathway inhibitor upregulates CXCR7 expression and enhances CXCL12-mediated migration in chronic lymphocytic leukemia
por: Cui, Xue Yan, et al.
Publicado: (2021)

Malignant Phyllodes Tumor and Acute Megakaryoblastic Leukemia Sharing a Common Clonal Origin
por: Fløisand, Yngvar, et al.
Publicado: (2013)

A tumor microenvironment model of chronic lymphocytic leukemia enables drug sensitivity testing to guide precision medicine
por: Hermansen, Johanne U., et al.
Publicado: (2023)

Inheritance of Susceptibility to Malignant Blood Disorders
por: Jønsson, Viggo, et al.
Publicado: (2019)

P613: ANALYSIS OF EX-VIVO RESPONSE TO SINGLE DRUGS AND DRUG COMBINATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENT SAMPLES
por: Miranda Santana, Leonardo, et al.
Publicado: (2023)

Body weight, body composition and survival after 1 year: follow-up of a nutritional intervention trial in allo-HSCT recipients
por: Skaarud, K. J., et al.
Publicado: (2019)

Hepatitis B Virus Reactivation in a Chronic Lymphocytic Leukemia Patient Treated with Ibrutinib
por: Choi, Jung Hye, et al.
Publicado: (2023)

Neutropenia caused by hairy cell leukemia in a patient with myelofibrosis secondary to polycythemia vera: a case report
por: Habberstad, Andreas Hanssønn, et al.
Publicado: (2018)

Use of anticoagulants and antiplatelet in patients with chronic lymphocytic leukaemia treated with single‐agent ibrutinib
por: Jones, Jeffrey A., et al.
Publicado: (2017)

Hepatitis B Virus Reactivation under Ibrutinib Treatment in a Patient with Chronic Lymphocytic Leukemia
por: İskender, Gülşen, et al.
Publicado: (2020)

Antineoplastics: COVID-19 infection and emergence of ibrutinib resistance in chronic lymphocytic leukaemia: case report
Publicado: (2021)

Revealing a Phenotypical Appearance of Ibrutinib Resistance in Patients With Chronic Lymphocytic Leukaemia by Flow Cytometry
por: Takács, Ferenc, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_86g4qetpcll46d22o1a1asdt99